Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Lambert-Eaton syndrome.

R G Smith1, S H Appel

  • 1Department of Neurology, Baylor College of Medicine, Houston.

Hospital Practice (Office Ed.)
|December 15, 1992
PubMed
Summary
This summary is machine-generated.

This rare neurologic disease, caused by antibodies targeting an ion channel complex, offers insights into receptor diseases and acetylcholine release at neuromuscular junctions.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tripeptide growth hormone secretagogues.

Bioorganic & medicinal chemistry letters·1999
Same author

Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues.

Bioorganic & medicinal chemistry letters·1999
Same author

Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.

Journal of neurochemistry·1998
Same author

Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients.

Annals of neurology·1998
Same author

Infections with the CardioWest total artificial heart.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1998
Same author

Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors.

Genomics·1998

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Background:

  • A rare myasthenic disorder has been identified.
  • This condition is the first neurologic disease linked to antibodies against an ion channel complex.

Purpose of the Study:

  • To clarify the pathobiology of receptor diseases.
  • To enhance understanding of normal acetylcholine release and neuromuscular junction function.

Main Methods:

  • This study focuses on a rare myasthenic disorder.
  • The research investigates antibodies against an ion channel complex.

Main Results:

  • The disorder is caused by antibodies targeting an ion channel complex.
  • This provides a unique model for studying receptor diseases.

Conclusions:

  • This condition advances the understanding of neurologic diseases.
  • It offers insights into acetylcholine release and neuromuscular junction biology.